Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

84.74 +0.63 (+0.75%)
Official Closing Price Updated: 4:10 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
3 Dividend Stocks I'll Never Sell
Via The Motley Fool
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:CLOV) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence Fraud
Exposures Artificial Intelligence Legal
Nasdaq Gains 1% Ahead Of Nvidia Earnings: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone
Via Benzinga
Earnings Preview For Medtronic
Via Benzinga
Analyst Expectations For Medtronic's Future
Via Benzinga
Medtronic Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Via Benzinga
Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential
From FN Media Group LLC
Via GlobeNewswire
Medtronic (MDT) Q2 2025 Earnings Call Transcript
MDT earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
15 Analysts Assess Medtronic: What You Need To Know
Via Benzinga
Peering Into Medtronic's Recent Short Interest
Via Benzinga
Medtronic Inc.: Dividend Stock Analysis
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management and other medical markets. 
Via Talk Markets
Gold Moves Higher; Medtronic Posts Upbeat Results
Via Benzinga
Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook
Medtronic Q2 2025 revenue hits $8.4 billion with 5.3% YoY growth. Raised FY25 organic revenue growth guidance to 4.75%-5% amid solid segment gains. 
Via Benzinga
Medtronic Beats And Raises, But Shares Flirt With A Sell Zone
Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in premarket trading. 
Via Investor's Business Daily
US Stocks Likely To Open In Red Amid Mounting Geopolitical Tensions: Wharton Economist Says Market Trajectory Will 'Heavily Depend' On Trump's Tariff Plans
U.S. stocks could open on a negative note on Tuesday after the averages maintained a cautious stance last week. Futures of all three major indices were slightly down on Tuesday, pointing to a cautious... 
Via Benzinga
Topics Government
Exposures Political
NYSE:MDT Shows Potential for a Breakout.
Good technical signals and a possible breakout for MEDTRONIC PLC. 
Via Chartmill
Earnings Scheduled For November 19, 2024
Via Benzinga
Nasdaq Gains Over 100 Points As Tesla Surges: Investor Sentiment Declines, Fear & Greed Index Remains In 'Neutral' Zone
Via Benzinga
Walmart, Lowe's And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Top Analyst Reports For Oracle, Micron Technology & Medtronic
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp., Micron Technology, Inc., and Medtronic plc, as well as a micro-cap stock The Cato Corp.​ 
Via Talk Markets
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
A Balancing Act: The Unseen Realities of Life with T1D
(BPT) - People living with type 1 diabetes live with an invisible burden. Between nonstop checking and balancing blood glucose levels, anxiety about every meal or snack, plus juggling everyday... 
Via Brandpoint
2 Dividend Stocks to Buy for a Lifetime of Passive Income
These are the kinds of stocks that can allow investors to sleep easy at night. 
Via The Motley Fool
Stryker’s Acquisition Spree: Double-Digit Growth on the Horizon
Stryker has acquired several firms over the last few months, including one related to AI. Do these purchases make the stock a buy? 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Medtronic Recalls MiniMed Pump Due To Battery Life Concerns
Medtronic issued a recall on its MiniMed insulin pumps following reports of battery life issues that may lead to insulin delivery stoppages. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit 
Via News Direct
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
Via Talk Markets
Truffles Vein Specialists Expands with Newest Location at 5041 Dallas Hwy, Powder Springs, Georgia, Offering Advanced Vein Care
Truffles Vein Specialists opens a new clinic at 5041 Dallas Hwy, Powder Springs, delivering expert minimally invasive treatments for varicose veins, spider veins, and other vascular conditions. 
Via PRUnderground
The Smartest Dividend Stocks to Buy With $10,000 Right Now
If you have $10k today, while the market is at all-time highs, think about diversification and downside risk. 
Via The Motley Fool
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.